The impact of age on survival in CLL patients receiving ibrutinib as initial therapy Meeting Abstract
| Authors: | Ujjani, C.; Mato, A.; Hill, B.; Allan, J.; Lansigan, E.; Skarbnik, A.; Jacobs, R.; Thompson, M.; Svoboda, J.; Tuncer, H. H.; Pagel, J.; Brander, D.; Cheson, B. D.; Barr, P.; Zent, C. S.; Rhodes, J.; Roeker, L.; Pu, J.; Handunnetti, S.; Nabhan, C.; Shah, N.; Goy, A.; Pickens, P.; Schuster, S.; Lamanna, N.; Sehgal, A.; Tam, C.; Shadman, M. |
| Abstract Title: | The impact of age on survival in CLL patients receiving ibrutinib as initial therapy |
| Meeting Title: | 18th International Workshop on Chronic Lymphocytic Leukemia |
| Journal Title: | Leukemia and Lymphoma |
| Volume: | 61 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Sept 20-23 |
| Meeting Location: | Edinburgh, United Kingdom |
| ISSN: | 1042-8194 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2020-01-01 |
| Start Page: | 156 |
| End Page: | 158 |
| Language: | English |
| ACCESSION: | WOS:000534385400113 |
| PROVIDER: | wos |
| PUBMED: | 32436402 |
| DOI: | 10.1080/10428194.2020.1732667 |
| Notes: | Meeting Abstract: 2073 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
